Among the number of partnerships that Halo has been part of this week, comes its most recent with ilo Vapor ™, where the duo announced its plans to launch Levata. Levata is supposedly founded on DabTabs technology, which accurately depicts cannabidiol (CBD) dosage.
According to the press release, Levata measures CBD dosage in the finest way possible, resulting in increased accuracy. Said measurement capacities has been done in order to understand the presence of terpenes as well. The ultimate goal is allegedly to ensure that consumers can control and keep track of how much CBD is being ingested via each vape pen-styled device.
As for when the cannabis extraction company will be making Levata available to consumers, it has been disclosed that it should take place early October 2019 through its online platforms in both the U.S. and Europe.
CEO and Co-Founder of ilo Vapor, Michael Lindars, has expressed gratitude in being able to bring together its DabTabs technology with CBD, excitedly highlighting that it is “the first of many strategic moves to introduce true, clean vaporization into this developing wellness space.”
CEO of Halo, Sidhu also expressed a similar sentiment, adding that the inclusion of the Levata collection is a step towards diversifying the firm’s revenue base.
As previously reported, Halo has gotten into a partnership with XES Sensual, which focuses on enhancing sexual pleasure in women and couples. Clearly, Sidhu’s claims of focusing on the “sale of innovative CBD products,” is evident as they continue to seek products and methods that stand out from the rest.